November 20, 2006
Laser to drusen trial
Analysis of:
Laser Treatment Ineffective In Preventing Vision Loss In Early Age-Related Macular Degeneration | www.pharma-lexicon.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Implications: It is not surprising that laser therapy is not effective for patients with macular degeneration. Initially there was a significant interest in this therapy, but as this well designed trial has shown us that thermal treatment is not the answer for dry ARMD. AREDS I and AREDS II are now the most important vitamin related studies with ARMD. The future for dry ARMD lies potentially with encapsulated compounds that may be delivered to the back of the eye for geographic atrophy. Currently the Anti-VEGF agents Lucentis and Avastin are the gold standard for wet ARMD. PDT in combination with these agents may be useful for decreasing the number in the injections involved.
Analysis:
Analysis:
This will have no impact on the way patients are currently treated.
Report a Concern
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Use of Antipsychotics in Children Is Criticized
www.nytimes.com
Scientists recommend 'black box' for Avastin
www.fiercepharma.com
Are Costly Diabetes Pills Doing Any Good?
www.pharmalot.com
How a Drug Maker Tries to Outwit Generics
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

